Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing
T. S. Dharmarajan
Journal of the American Medical Directors Association (2020) Vol. 22, Iss. 1, pp. 15-22
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 3, pp. 645-651
Closed Access | Times Cited: 6
Effectiveness of Changing Drug Classes in Patients With Refractory Laryngopharyngeal Reflux Disease
E Herman, Sven Saussez, Jérôme R. Lechien
Otolaryngology (2024)
Closed Access | Times Cited: 6
Effect of proton pump inhibitor (lansoprazole) on adverse drug reactions and rational drug use in elderly patients with chronic heart failure
Lei Zhou, Su‐Juan Kuang, Yuan Lv, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1290-1301
Closed Access
Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors
Massimo Carollo, Salvatore Crisafulli, Margherita Selleri, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2419851-e2419851
Open Access | Times Cited: 3
Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis
Xuejiao Xun, Qifan Yin, Yuhao Fu, et al.
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 5, pp. 524-532
Closed Access | Times Cited: 21
Targeting TRPV1 signaling: Galangin improves ethanol-induced gastric mucosal injury
Kaiwen Lin, Zhongtao Wang, Erhao Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118605-118605
Closed Access | Times Cited: 2
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis
Wanshu Li, Ya-Nan Yu, Minghui Li, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1381-1390
Closed Access | Times Cited: 2
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases
Satoru Mitsuboshi, Hirofumi Hamano, Yurika Kuniki, et al.
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 11, pp. 1255-1263
Closed Access | Times Cited: 6
The impact of deprescribing interventions on oral proton pump inhibitor utilisation in a Singapore tertiary hospital: A quality improvement initiative
Christina Tan, Shi Xun Lee, Tat Ming Ng
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 1, pp. 8-15
Open Access | Times Cited: 10
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study
Asher Shafrir, Ariel A. Benson, Lior H. Katz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Inappropriate proton-pump inhibitor prescribing in primary care – an observational study with quality circles
Renata Vidonscky Lüthold, Nicole Christin Henz, Connor Fuhrer, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 9, pp. 40119-40119
Open Access | Times Cited: 5
Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection
Hafez Al-Momani, Iman Aolymat
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
The silent epidemic: Inappropriate use of proton pump inhibitors among hospitalized patients
Mohamed Mohamed, Mira Itani, Mostafa Abohelwa, et al.
Arab Journal of Gastroenterology (2024)
Closed Access | Times Cited: 1
Quality in Gastroenterology
David Fudman, Shaharyar Zuberi, Joseph D. Feuerstein
Springer eBooks (2024), pp. 1-9
Closed Access | Times Cited: 1
Association Between Proton Pump Inhibitor Use and Overactive Bladder Risk in Adults: A Cross-Sectional Study
Yuan-Zhuo Du, Jiahao Liu, Fu‐Chun Zheng, et al.
Urology (2024)
Closed Access | Times Cited: 1
Medications in Post-Acute and Long-Term Care: Challenges and Controversies
Philip D. Sloane, Nicole Brandt, Antonio Cherubini, et al.
Journal of the American Medical Directors Association (2020) Vol. 22, Iss. 1, pp. 1-5
Closed Access | Times Cited: 11
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults
Yue Ma, Shu Li, Hongxi Yang, et al.
Atherosclerosis (2022) Vol. 358, pp. 47-54
Closed Access | Times Cited: 7
The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study
Fangfang Jiang, Canqing Yu, Zheng Zhang, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 1, pp. 115-125
Closed Access | Times Cited: 3
The adverse effects of commonly used medications on male fertility: a comprehensive review
Armin Ghomeshi, Boris Yang, Thomas A. Masterson
F&S Reviews (2023) Vol. 4, Iss. 3, pp. 176-186
Closed Access | Times Cited: 3
Proton Pump Inhibitor Deprescription Prospective Study in Patients Without Indication: Are There Differences in Proportion of Restarts According to Withdrawal Strategy?
Anna Barraquer Comes, Pedro Roy Millán
Journal of Pharmacy Technology (2023) Vol. 39, Iss. 5, pp. 224-230
Open Access | Times Cited: 3
Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia
Ghazwa B. Korayem, Raghad Alkanhal, Raghad Almass, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 5079-5089
Open Access | Times Cited: 6
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
Carolla El Chamieh, Islam Amine Larabi, Solène M. Laville, et al.
Toxins (2023) Vol. 15, Iss. 4, pp. 276-276
Open Access | Times Cited: 2
Potenziell inadäquate Medikation für ältere Menschen – PRISCUS 2.0
Petra Thürmann, Nina‐Kristin Mann, Anette Zawinell, et al.
Springer eBooks (2022), pp. 51-76
Closed Access | Times Cited: 4
The Janus-like Association between Proton Pump Inhibitors and Dementia
Anna Papazoglou, Muhammad Imran Arshaad, Christina Henseler, et al.
Current Alzheimer Research (2021) Vol. 18, Iss. 6, pp. 453-469
Open Access | Times Cited: 4
Inhibidores de bomba de protones vs. antagonistas del receptor 2 de histamina en la protección gástrica en el paciente anticoagulado: ¿qué ha definido la evidencia?
Angie S. Duarte-Duran, Federico Arango-Moreno, Karen D. Palomino-Mendoza, et al.
Revista Peruana de Investigación en Salud (2024) Vol. 8, Iss. 1, pp. e1895-e1895
Open Access
Page 1 - Next Page

Scroll to top